Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Events

26 Oct 2021

Microdose Announces Cybin as Wonderland Private Room Sponsor

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine...

By Microdose

Events

25 Oct 2021

Microdose Announces KGK Science as Wonderland Press Lounge Sponsor

The leader in the business of psychedelics, Microdose is taking the next step in industry events with Wonderland: Miami....

By Microdose

Events

25 Oct 2021

Microdose Announces Cybin as Wonderland Bronze Sponsor

The leader in the business of psychedelics, Microdose is taking the next step in industry events with Wonderland: Miami....

By Microdose

Events

25 Oct 2021

Microdose Announces Awakn Life Sciences as Wonderland Business Lounge Sponsor

Microdose Announces Awakn Life Sciences as Wonderland Business Lounge Sponsor...

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Events

22 Oct 2021

Microdose Announces Tabula Rasa Ventures as Wonderland Silver Sponsor

Microdose Announces Tabula Rasa Ventures as Wonderland Silver Sponsor...

By Microdose

Events

22 Oct 2021

Microdose Announces Wesana Health as Wonderland Platinum Sponsor

Microdose Announces Wesana Health as Wonderland Platinum Sponsor...

By Microdose

Psychedelic Groundbreakers

21 Oct 2021

Psychedelic Groundbreakers: Silo Wellness

This week's Psychedelic Groundbreaker is Silo Wellness, a growth-oriented holding company focused on functional mushroom and psychedelic opportunities....

By Microdose

Events

21 Oct 2021

Microdose Announces Origin Therapeutics as Wonderland Silver Sponsor

Microdose Announces Origin Therapeutics as Wonderland Silver Sponsor...

By Microdose

Events

21 Oct 2021

Microdose Announces MINDCURE as Wonderland Silver Sponsor

Microdose Announces MINDCURE as Wonderland Silver Sponsor...

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.